Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer
ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, announced the appointment […]
PureCycle Announces Key Leadership Changes, New Chief Executive Officer
Today, PureCycle Technologies, Inc. (NASDAQ: PCT) announced three key leadership changes effective August 5, 2022, that are […]
Coave Therapeutics Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Next-generation Gene Therapies Targeting CNS Diseases
Coave Therapeutics (‘Coave’), a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS […]
Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive Officer
Dunad Therapeutics, a biopharmaceutical company developing small molecule covalent therapies based on novel insights from […]
INOVIO Appoints Dr. Michael Sumner, MB BS, MBA as Chief Medical Officer
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect […]
MicroTransponder Raises $53M, Appoints New CEO
MicroTransponder®, Inc. closed an oversubscribed $53 million Series E funding round led by US Venture Partners (USVP), a multi-stage investment […]
Börje Haraldsson Appointed Ceo of Oncorena AB
Oncorena AB, which is developing a new and potentially groundbreaking treatment for patients with advanced […]
Former Amazon, Oracle Exec Greg Born Joins Amino Health as Chief Growth Officer
Amino Health, the leading digital healthcare guidance platform, today announced that senior global operations executive Greg […]
Mdgroup Appoints Laquinta Jernigan as Chief Operating Officer
mdgroup, the leading global digital and patient-health servicing company pioneering a patient-first approach to clinical […]
seqWell Appoints Dr Amy Liao to Board of Directors
seqWell, a global provider of genomic library workflow solutions including the plexWell™ next-generation sequencing (NGS) multiplexing technology, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more